Related Experiment Videos
Acute asthma. Single dose oral steroids in paediatric community clinics
L Horowitz1, O Zafrir, S Gilboa
1Department of Paediatrics, Meir General Hospital, Sapir Medical Center, Kfar Saba, Israel.
Insights
A single oral dose of steroids significantly improved outcomes for children with mild to moderate asthma attacks. This treatment prevented deterioration, eased symptoms faster, and avoided hospitalization, offering rapid relief.
Area of Science:
- Pediatric Pulmonology
- Clinical Pediatrics
- Pharmacology
Background:
- Acute asthma attacks in children are commonly treated with bronchodilators and steroids.
- The efficacy of a single oral steroid dose in ambulatory pediatric asthma management requires further elucidation.
Purpose of the Study:
- To evaluate the effectiveness of a single oral steroid dose compared to placebo in treating acute mild to moderate asthma attacks in children.
Main Methods:
- A double-blind, randomized study involving 70 children with acute asthma.
- Participants received either a single oral dose of prednisone (20-40 mg) or a placebo.
- Patient outcomes were observed over a 72-hour period.
Main Results:
- A single oral steroid dose significantly improved the clinical course of pediatric asthma.
- Steroid treatment prevented deterioration, accelerated symptom relief, and eliminated the need for hospitalization.
- No hospitalizations were reported in the steroid group.
Conclusions:
- Early administration of a single oral steroid dose is a beneficial treatment modality for acute mild to moderate asthma in children.
- Pediatricians are encouraged to incorporate this early steroid intervention into standard ambulatory care for asthma attacks.
- This approach effectively relieves and shortens pediatric asthma-related distress.
Abstract:
The treatment of an acute asthma attack usually includes bronchodilators and often steroids. We studied 70 children who were randomly assigned to receive either single dose steroids (oral prednisone: 20-40 mg) or placebo on a double blind basis. The time course of the observation was 72 h. We demonstrate that a single dose of steroids, given orally in paediatric community clinics during an acute mild to moderate asthma attack, significantly improves the patient's course; deterioration was prevented, symptoms were relieved faster, and hospitalization was not required. We encourage paediatricians in the ambulatory clinics to follow this treatment modality and to give, in addition to other conventional therapy, a single oral dose of steroids early in the asthma attack, in order to relieve and shorten the child's distress.